Multiresistant bacteria as a hospital epidemic problem

被引:37
作者
Dennesen, PJW
Bonten, MJM
Weinstein, RA
机构
[1] Univ Hosp Maastricht, Dept Internal Med, NL-6202 AZ Maastricht, Netherlands
[2] Cook Cty Hosp, Dept Med, Div Infect Dis, Chicago, IL 60612 USA
[3] Rush Med Sch, Chicago, IL USA
关键词
antibiotic resistance; enterococci; Enterobacteriaceae; epidemiology; infection control; Staphylococcus aureus;
D O I
10.3109/07853899808999401
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since the introduction of antibiotics into clinical use, bacteria have protected themselves by developing antibiotic resistance mechanisms. Currently, there are increasing problems worldwide with multiresistant bacteria. These problems are especially evident within hospitals, where they frequently present as nosocomial epidemics. Currently, the most important nosocomial resistance problems on a global scale are caused by methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and Enterobacteriaceae with plasmid-encoded extended-spectrum beta-lactamases. In this review we describe the characteristics of nosocomial epidemics of these three groups of multiresistant nosocomial pathogens. Despite the differences in bacterial species, the differences in mechanisms of resistance, the different ecological niches and the different infections caused by these pathogens, there are striking similarities in the variables determining nosocomial spread. The existence of each of these multiresistant micro-organisms and their concurrent spread seem to result from extensive antibiotic use and lapses in compliance with infection control measures. Problems with these bacteria became evident as monoclonal outbreaks, soon followed by establishment of endemicity especially in intensive care units. Finally, endemicity seems to be established on general hospital wards and in chronic care facilities and nursing homes, creating a continuous influx of colonized patients into special care wards. High compliance with infection control measures and a prudent and more restrictive use of antibiotics are the key measures to prevent these epidemics.
引用
收藏
页码:176 / 185
页数:10
相关论文
共 106 条
[71]   ENTEROCOCCI RESISTANT TO MULTIPLE ANTIMICROBIAL AGENTS, INCLUDING VANCOMYCIN - ESTABLISHMENT OF ENDEMICITY IN A UNIVERSITY MEDICAL-CENTER [J].
MORRIS, JG ;
SHAY, DK ;
HEBDEN, JN ;
MCCARTER, RJ ;
PERDUE, BE ;
JARVIS, W ;
JOHNSON, JA ;
DOWLING, TC ;
POLISH, LB ;
SCHWALBE, RS .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (04) :250-259
[72]   METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS - A CONSENSUS REVIEW OF THE MICROBIOLOGY, PATHOGENESIS, AND EPIDEMIOLOGY WITH IMPLICATIONS FOR PREVENTION AND MANAGEMENT [J].
MULLIGAN, ME ;
MURRAYLEISURE, KA ;
RIBNER, BS ;
STANDIFORD, HC ;
JOHN, JF ;
KORVICK, JA ;
KAUFFMAN, CA ;
YU, VL .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (03) :313-328
[73]   TRANSFERABLE BETA-LACTAMASE - A NEW MECHANISM FOR INVITRO PENICILLIN RESISTANCE IN STREPTOCOCCUS-FAECALIS [J].
MURRAY, BE ;
MEDERSKISAMAROJ, B .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (03) :1168-1171
[74]   THE LIFE AND TIMES OF THE ENTEROCOCCUS [J].
MURRAY, BE .
CLINICAL MICROBIOLOGY REVIEWS, 1990, 3 (01) :46-65
[75]   OUTBREAK OF CEFTAZIDIME RESISTANCE DUE TO A NOVEL EXTENDED-SPECTRUM BETA-LACTAMASE IN ISOLATES FROM CANCER-PATIENTS [J].
NAUMOVSKI, L ;
QUINN, JP ;
MIYASHIRO, D ;
PATEL, M ;
BUSH, K ;
SINGER, SB ;
GRAVES, D ;
PALZKILL, T ;
ARVIN, AM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) :1991-1996
[76]   THE CRISIS IN ANTIBIOTIC-RESISTANCE [J].
NEU, HC .
SCIENCE, 1992, 257 (5073) :1064-1073
[77]  
NOBLE WC, 1992, FEMS MICROBIOL LETT, V93, P195
[78]   NOVEL PLASMID-MEDIATED BETA-LACTAMASE (MIR-1) CONFERRING RESISTANCE TO OXYIMINO-LACTAMS AND ALPHA-METHOXY BETA-LACTAMS IN CLINICAL ISOLATES OF KLEBSIELLA-PNEUMONIAE [J].
PAPANICOLAOU, GA ;
MEDEIROS, AA ;
JACOBY, GA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) :2200-2209
[79]  
PATERSON DL, 1997, P 37 INT C ANT AG CH
[80]   MUTANTS OF THE TEM-1 BETA-LACTAMASE CONFERRING RESISTANCE TO CEFTAZIDIME [J].
PAYNE, DJ ;
MARRIOTT, MS ;
AMYES, SGB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 (02) :103-110